News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma
ksgr.ch
Nov 15, 2024, 14:24

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:

“ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma – Radiotherapy and Oncology.

IDH-mutant grade 2 and 3 diffuse gliomas have a long overall survival.

Clinical management balances disease control and preserving neurological function.

Recommendations for radiation target volumes and treatment dose.”

ESTRO-EANO

ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma

Authors: Brigitta G. Baumert, Jaap P. M. Jaspers, Vera C. Keil, Norbert Galldiks, Ewa Izycka-Swieszewska, Beate Timmermann, Anca L. Grosu,  Giuseppe Minniti, Umberto Ricardi, Frédéric Dhermain, Damien C. Weber, Martin van den Bent, Roberta Rudà, Maximilian Niyazi, Sara Erridge

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

More posts featuring Elisabetta Bonzano.

Anca L. Grosu Beate Timmermann Brigitta G. Baumert cancer Damien C. Weber ESTRO-EANO Ewa Izycka-Swieszewska Frédéric Dhermain Giuseppe Minniti Jaap P. M. Jaspers Martin van den Bent Maximilian Niyazi Norbert Galldiks OncoDaily Oncology Roberta Ruda Sara Erridge Umberto Ricardi Vera C. Keil
Special Coverage
Blog
Nov 15, 2024, 14:24
ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma
Blog
Nov 15, 2024, 14:18
Alba Fiorentino: Honored to participate in the Oligocare study organized by the ESTRO and EORTC
Blog
Nov 15, 2024, 14:17
OncoInfluencers to Follow on Social Media: Dr. Dégi László Csaba
Blog
Nov 15, 2024, 14:11
Olubukola Ayodele: Inaugural Cancer Health Disparities Day Event
Insight
Nov 15, 2024, 14:00
Myeloma Paper of the Day, November 15th, suggested by Robert Orlowski
Insight
Nov 15, 2024, 13:56
Article of the Week, Suggested by the BPDCN International Registry
Blog
Nov 15, 2024, 12:58
Herbert Loong: Kicking off the CTOS2024 with Hayden Snow
Career
Nov 15, 2024, 12:53
Jasmine Kamboj - Candidate for ASCO Nominating Committee
Insight
Nov 15, 2024, 12:51
Anand Patel: Proud to highlight 3 abstracts at ASH24
Blog
Nov 15, 2024, 12:47
Rana McKay: Surgical castration allows access to abiraterone to Brazilians with mPC
Blog
Nov 15, 2024, 12:45
Rana McKay: Integration of HSD3B1 into germline testing and clinical trials in Prostate Cancer
Opinion
Nov 15, 2024, 12:42
Rana McKay: Updates in prostate cancer treatments on Community Think Tank